Related Articles
Novel strategies in the treatment of castration-resistant prostate cancer (Review)
Risk stratification of castration‑resistant prostate cancer patients treated with cabazitaxel
Low-dose docetaxel, estramustine and prednisolone combination chemotherapy for castration-resistant prostate cancer
Neuroendocrine differentiation in castration-resistant prostate cancer: A case report
Baseline prostate-specific antigen levels following treatment with abiraterone acetate as a prognostic factor in castration-resistant prostate cancer